Falsely Elevated 25-Hydroxy-Vitamin D Levels in Patients with Hypercalcemia.

Case Rep Endocrinol

Department of Endocrinology, Einstein Endocrine Associates, 50 East Township Line Road Medical Arts Building, Suite G01, Elkins Park, PA 19027, USA.

Published: August 2020

AI Article Synopsis

  • * The diagnosis relies heavily on lab tests, particularly accurate measurements of parathyroid hormone and vitamin D levels.
  • * Elevated vitamin D levels can be misleading in patients with high paraprotein levels, such as those with multiple myeloma, leading to false readings in hypercalcemia cases.

Article Abstract

Symptomatic hypercalcemia is a commonly encountered clinical scenario. Though it is important to collect detailed history to find clinical clues connecting to the etiology of hypercalcemia, the diagnostic workup of hypercalcemia depends heavily on laboratory analysis. Accurate measurement of the parathyroid hormone and vitamin D levels is essential. However, commercial laboratory measurement of vitamin D levels can be erroneous in the setting of abundant paraprotein in the serum. One of the most common conditions that can cause an increased amount of paraproteins is multiple myeloma. We report 2 cases of falsely elevated 25-hydroxy-vitamin D levels in patients presenting with hypercalcemia and an underlying diagnosis of MM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431955PMC
http://dx.doi.org/10.1155/2020/8873506DOI Listing

Publication Analysis

Top Keywords

falsely elevated
8
elevated 25-hydroxy-vitamin
8
25-hydroxy-vitamin levels
8
levels patients
8
vitamin levels
8
hypercalcemia
5
levels
4
patients hypercalcemia
4
hypercalcemia symptomatic
4
symptomatic hypercalcemia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!